These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 3924048)
41. Efficacy of combination of DFMO and diminazene aceturate in the treatment of late stage Trypanosoma brucei brucei infection in rats. Onyeyili PA; Onwualu JE Trop Med Parasitol; 1991 Jun; 42(2):143-5. PubMed ID: 1896772 [TBL] [Abstract][Full Text] [Related]
42. Effects of polyamines on two strains of Trypanosoma brucei in infected rats and in vitro culture. Nishimura K; Yanase T; Araki N; Ohnishi Y; Kozaki S; Shima K; Asakura M; Samosomsuk W; Yamasaki S J Parasitol; 2006 Apr; 92(2):211-7. PubMed ID: 16729674 [TBL] [Abstract][Full Text] [Related]
43. Enhancement of ovulation in the rat by DL-alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase. Carpenter JR; Fozard JR Eur J Pharmacol; 1982 May; 80(2-3):263-6. PubMed ID: 6809478 [TBL] [Abstract][Full Text] [Related]
44. Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase. Slotkin TA; Seidler FJ; Trepanier PA; Whitmore WL; Lerea L; Barnes GA; Weigel SJ; Bartolome J J Pharmacol Exp Ther; 1982 Sep; 222(3):741-5. PubMed ID: 6809932 [TBL] [Abstract][Full Text] [Related]
45. Eflornithine for the treatment of human African trypanosomiasis. Burri C; Brun R Parasitol Res; 2003 Jun; 90 Supp 1():S49-52. PubMed ID: 12811548 [TBL] [Abstract][Full Text] [Related]
46. Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model. Dauchy FA; Bonhivers M; Landrein N; Dacheux D; Courtois P; Lauruol F; Daulouède S; Vincendeau P; Robinson DR PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005125. PubMed ID: 27855164 [TBL] [Abstract][Full Text] [Related]
47. X-ray structure of ornithine decarboxylase from Trypanosoma brucei: the native structure and the structure in complex with alpha-difluoromethylornithine. Grishin NV; Osterman AL; Brooks HB; Phillips MA; Goldsmith EJ Biochemistry; 1999 Nov; 38(46):15174-84. PubMed ID: 10563800 [TBL] [Abstract][Full Text] [Related]
48. A molecular mechanism for eflornithine resistance in African trypanosomes. Vincent IM; Creek D; Watson DG; Kamleh MA; Woods DJ; Wong PE; Burchmore RJ; Barrett MP PLoS Pathog; 2010 Nov; 6(11):e1001204. PubMed ID: 21124824 [TBL] [Abstract][Full Text] [Related]
49. Role of antibody in the elimination of trypanosomes after DL-alpha-difluoromethylornithine chemotherapy. de Gee AL; McCann PP; Mansfield JM J Parasitol; 1983 Oct; 69(5):818-22. PubMed ID: 6423794 [TBL] [Abstract][Full Text] [Related]
50. Impairment of macrophage function by inhibitors of ornithine decarboxylase activity. Kierszenbaum F; Wirth JJ; McCann PP; Sjoerdsma A Infect Immun; 1987 Oct; 55(10):2461-4. PubMed ID: 3115898 [TBL] [Abstract][Full Text] [Related]
51. Difluoromethylornithine irreversibly inactivates ornithine decarboxylase of Pseudomonas aeruginosa, but does not inhibit the enzymes of Escherichia coli. Kallio A; McCann PP Biochem J; 1981 Oct; 200(1):69-75. PubMed ID: 6800359 [TBL] [Abstract][Full Text] [Related]
52. Inhibition of ornithine decarboxylase activity and cell growth by diamines: a comparison between the effects of two homologs, 1,3-diaminopropane and 1,4-diaminobutane (putrescine). Linden M; Oredsson SM; Anehus S; Heby O J Cell Biochem; 1985; 29(2):105-13. PubMed ID: 3934184 [TBL] [Abstract][Full Text] [Related]
53. Accumulation of decarboxylated S-adenosyl-L-methionine in mammalian cells as a consequence of the inhibition of putrescine biosynthesis. Mamont PS; Danzin C; Wagner J; Siat M; Joder-Ohlenbusch AM; Claverie N Eur J Biochem; 1982 Apr; 123(3):499-504. PubMed ID: 6804235 [TBL] [Abstract][Full Text] [Related]
54. Chemotherapy of trypanosomiasis: the potentiation of antimonial compounds by difluoromethylornithine (DFMO). Jennings FW Trop Med Parasitol; 1991 Jun; 42(2):135-8. PubMed ID: 1654590 [TBL] [Abstract][Full Text] [Related]
55. Validation of spermidine synthase as a drug target in African trypanosomes. Taylor MC; Kaur H; Blessington B; Kelly JM; Wilkinson SR Biochem J; 2008 Jan; 409(2):563-9. PubMed ID: 17916066 [TBL] [Abstract][Full Text] [Related]
56. Polyamine biosynthesis and skin tumor promotion: inhibition of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin tumor formation by the irreversible inhibitor of ornithine decarboxylase alpha-difluoromethylornithine. Takigawa M; Verma AK; Simsiman RC; Boutwell RK Biochem Biophys Res Commun; 1982 Apr; 105(3):969-76. PubMed ID: 6807316 [No Abstract] [Full Text] [Related]
58. Chemotherapy of trypanosomiasis: the use of guanylhydrazone compounds in the treatment of experimental murine trypanosomiasis. Jennings FW; Ulrich P; Cerami A Trop Med Parasitol; 1987 Sep; 38(3):181-6. PubMed ID: 3124253 [TBL] [Abstract][Full Text] [Related]
59. Characterization of alpha-difluoromethylornithine resistant Leishmania donovani and its susceptibility to other inhibitors of the polyamine biosynthetic pathway. Mukhopadhyay R; Kapoor P; Madhubala R Pharmacol Res; 1996; 34(1-2):43-6. PubMed ID: 8981555 [TBL] [Abstract][Full Text] [Related]
60. African sleeping sickness in the United States. Successful treatment with eflornithine. Petru AM; Azimi PH; Cummins SK; Sjoerdsma A Am J Dis Child; 1988 Feb; 142(2):224-8. PubMed ID: 3124603 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]